APUS vs AAPL: Which Stock is Better?
Side-by-side comparison of Apimeds Pharmaceuticals Us Inc and Apple Inc in 2026
APUS
Apimeds Pharmaceuticals Us Inc
$1.88
AAPL
Apple Inc
$269.84
Key Metrics Comparison
| Metric | APUS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $23.64M | N/A | APUS |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | 0.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze APUS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APUS or AAPL a better investment?
Comparing APUS and AAPL: Apimeds Pharmaceuticals Us Inc has a market cap of $23.64M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APUS and AAPL?
APUS (Apimeds Pharmaceuticals Us Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APUS or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APUS or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.0% for APUS.
Which company is more profitable: APUS or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for APUS.
Which is the larger company: APUS or AAPL?
Apimeds Pharmaceuticals Us Inc (APUS) is larger with a market cap of $23.64M compared to N/A for AAPL.
Should I buy APUS or AAPL in 2026?
Both APUS and AAPL have investment merit. APUS trades at $1.88 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APUS and AAPL stock?
Key differences: Market Cap ($23.64M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).